Top Story

When considering new technology, think about the three stakeholders

October 2, 2014
At the upcoming AAO meeting, we will see a variety of new devices and drugs that will excite us, challenge our current treatment regimens and leave us wondering who will pay for them. In weighing the value of any new offering, I consider three stakeholders: the medical drug and device industry, the physician practice and, most importantly, the patient.

Alcon announces top appointments

October 2, 2014
Alcon has named Eric Bruno as the new general manager for U.S. Vision Care, after Jim Murphy was promoted to president, Alcon Japan, according to a press…
figure Video

New IOLs increase depth of focus

October 2, 2014
LONDON – Manfred Tetz, MD, discusses early results with the Symfony IOL during the European Society of Cataract and Refractive Surgeons meeting here.

XOMA launches gevokizumab study for treatment of Behçet’s disease uveitis

October 1, 2014
XOMA announced the launch of a U.S. clinical trial to investigate the safety and efficacy of gevokizumab for the treatment of patients with Behçet’s disease…
More News Headlines »
Surgical Maneuvers Publication Exclusive
figure

Keratolimbal allograft may be used for ocular surface reconstruction in symblephara treatment

Ocular Surgery News U.S. Edition, September 25, 2014
Marjan Farid, MD
Symblepharon is adhesion of the eyelid palpebral conjunctiva to the bulbar conjunctiva. It may be partial or complete…
More »

Presbyopia surgeons rejoice at Apple Watch announcement

September 12, 2014
How cool is this? A watch that allows you to send and receive SMS messages, view photos and process emails? After…
More »
Meeting News Coverage Video
figure

Corneal inlay pocket implant technique produces good visual results

September 29, 2014
LONDON – At the European Society of Cataract and Refractive Surgeons meeting here, Wolfgang Riha, MD,
More »